In addition to Speeches, Posters presentations, Workshops, and Discussions, the conference also offers an unparalleled time for renewing professional relationships, for networking and for keeping up-to-date with variations in your challenging and expanding research work. Parkinson’s 2019 provide a platform of international standards where you can discuss and influence regarding key advances in Parkinson’s and Neurodegenerative diseases.
International Conference on Parkinson’s and Neurodegenerative diseases.
We invite participants around the world to Dubai, UAE for Parkinson’s 2020 held during December 30-31, 2019.
Parkinson’s deals with Neurological Syndromes caused due to leakage of electric impulse in neurons which leads to loss of communication. This kind of medical conditions are getting frequent in humans at present situations. It has been observed there are number of diseases associated with Neurological disorders for examples Parkinson’s diseases, Huntington’s, Alzheimer’s disease, brain tumours, Multiple Sclerosis, Spinal Muscular Atrophy, Brain Stroke, Epilepsy, Amyotrophic Lateral Sclerosis.
According to current survey Neurological disorders occupy first place in Europe Brain disorders are like Brain Tumour, Cerebral palsy, chiari malformation, Craniofacial, abnormalities, Craniosynostosis, Developmental disorders, Encephalopathy, Epilepsy are recognized by World Health Organization in Europe. It is been identified 1.2 million people in Europe are suffering with Parkinson’s approximately 260000 people in Germany, 200000 people in Italy, 150000 people in Spain, 120000 people in UK, 117000 people in France are suffering from Parkinson’s disease.
World Health Organization (WHO) and World Federation of Neurology (WFN) were collaborated after find the rate of Neurological disorders worldwide. An international Survey of Country Resources for Neurological disorders effects 109 countries and covering over 90% of the world’s population. This survey helps to collect valuable information regarding aspects of neurological care all around the world.
At National Institute of Health funding package is of $34 billion for the economic year 2017 to improve life of patients who are suffering from Parkinson’s disease and to raise the awareness on Neurological disorders around the World. PRP (Parkinson’s Research Program) fund received amount of $16 million annually to research in neuromuscular disorders such as Alzheimer’s, Parkinson’s disease & Huntington’s disease.
Why to attend?
International Conference on Parkinson’s and Neurodegenerative diseases provides best plat form for Neurologists, Neurosurgeons, Scientists, Clinical Industry Specialists, Neurology Experts, Young Researchers with an aim to make patients feel better with innovative research outcomes.
Neuro physicians, Neruo surgeons, Neurologists, Psychiatrist, Physiotherapists, Neruo Specialists, Researchers, Professors, Industrials Experts, Nutritional Scientists, Lecturers and Students from Academic study in Parkinson’s and Huntington’s diseases , Pharma researchers on Neurology and Neuroscience, Therapists and Diagnostic Exp
Organizing Committee – Parkinsons Congress 2018
University of South Florida
Texila American University
Andrey S. Tsvetkov
The University of Texas McGovern Medical School at Houston
Musthafa Mohamed Essa
Sultan Qaboos University
President and CEO
GALLY International Biomedical Research Consulting LLC
TRAINM Neuro Rehabilitation Center
Ivandro Soares Monteiro
EME Health Clinical Center.